Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

NeuroVive Conducting Late-Stage NeuroSTAT Trial

March 8, 2011 6:39 am | News | Comments

NeuroVive has signed an agreement with the European Brain Injury Consortium to conduct a European multi-center Phase 2/3 clinical trial of NeuroSTAT for neuroprotection in patients with traumatic brain injury.

TOPICS:

FDA Wants More Info on Xifaxan

March 8, 2011 6:32 am | News | Comments

Salix Pharmaceuticals Ltd. confirmed that the Food and Drug Administration wants more information about Salix's irritable bowel syndrome treatment Xifaxan, and is not ready to grant a new marketing approval.

TOPICS:

FDA Accepts Dapagliflozin Application

March 8, 2011 6:29 am | News | Comments

AstraZeneca PLC and Bristol-Myers Squibb Co. say the U.S. Food and Drug Administration has accepted for review a new drug application for diabetes drug dapagliflozin.

TOPICS:
Advertisement

Lycera Announces Research Collaboration with Merck

March 7, 2011 7:40 am | News | Comments

Lycera Corporation has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation.

TOPICS:

Sanofi Extends Offer for Genzyme

March 7, 2011 7:33 am | News | Comments

France's Sanofi-Aventis SA says it will extend its cash buyout offer for Genzyme until next month, as part of its agreed $20.1 billion takeover of the U.S.-based specialty drugmaker.

TOPICS:

Clinical Trial Data Coding Update

March 7, 2011 7:29 am | Drug Discovery & Development | Product Releases | Comments

Oracle announced Oracle Health Sciences Central Coding Release 3.0, a Web-based clinical trial data coding and dictionary management that promotes greater productivity for clinical trial teams.

TOPICS:

Two Camera Imaging Adapter

March 7, 2011 7:27 am | Drug Discovery & Development | Product Releases | Comments

Andor Technology plc launched the TuCam adapter for simultaneous two camera imaging.

TOPICS:

Scientists Create Cell Assembly Line

March 7, 2011 7:23 am | News | Comments

Borrowing a page from modern manufacturing, scientists from the Florida campus of The Scripps Research Institute have built a microscopic assembly line that mass produces synthetic cell-like compartments.

TOPICS:
Advertisement

Normal White Blood Cells May Cause Rare Leukemia

March 7, 2011 7:20 am | News | Comments

New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.

TOPICS:

Symphogen Receives U.S. Patent on Lead Cancer Compound

March 7, 2011 7:12 am | News | Comments

Symphogen has been granted a U.S. patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

TOPICS:

Primary Endpoints Met In Phase 3 Trial of Tofacitinib

March 7, 2011 7:10 am | News | Comments

Pfizer Inc. announced that the ORAL Sync Phase 3 study of tofacitinib,  an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints.

TOPICS:

Roche, RainDance Collaborate in Targeted Sequencing for ADME Research

March 7, 2011 7:04 am | News | Comments

RainDance Technologies, Inc., and 454 Life Sciences announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the investigation of drug absorption, distribution, metabolism, and excretion (ADME).

TOPICS:

Cardiomyocyte Biomarker Testing Revealed

March 7, 2011 7:00 am | News | Comments

GE Healthcare announced preliminary data from its ongoing structural cardiomyocyte biomarker collaboration with Genentech at the 50th Annual Meeting of The Society of Toxicology (SOT) in Washington D.C.

TOPICS:

Japan Halts Vaccines After Deaths of 4 Children

March 7, 2011 6:55 am | News | Comments

Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health ministry said.

TOPICS:

AstraZeneca Ends Production of Asthma Inhaler

March 7, 2011 6:53 am | News | Comments

AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading